3

FORM 3 SUBMISSION

Company: ORAMED PHARMACEUTICALS INC.
Filed: May 1, 2023
Period of Report: May 1, 2023
Accession Number: 0001209191-23-026305

View Document ↗ View on SEC.gov ↗